Vivity complements Alcon’s existing IOL portfolio by providing an additional option for cataract patients to treat presbyopia A first-of-its-kind, non-diffractive lens that offers a continuous ...

TORONTO, Nov. 17, 2020 /CNW/ - Alcon, the global leader in eye care, is pleased to announce the Canadian launch of AcrySof ® IQ Vivity ®, a first-of-its-kind, surgical lens designed to help cataract ...

GENEVA--(BUSINESS WIRE)-- Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, has commercially launched the first and only non-diffractive extended depth ...

VIENNA — In this Healio Video Perspective from the ESCRS meeting, Nic Reus, MD, presents the results of a real-world evidence study assessing the outcomes of the Vivity extended depth of focus IOL ...

Lance Kugler, MD, of Omaha, Neb.-based Kugler Vision, is slated to be the first surgeon in eastern Nebraska to use Acrysof IQ Vivity Lens from Geneva, Switzerland-based Alcon, according to an Oct. 27 ...

Two specialists at Phoenix-based Valley Eye Specialists were among the first group of surgeons in the nation to implant the Alcon Acrysof IQ Vivity Lens after FDA approval, according to a Feb. 1 news ...

Alcon (NYSE:ALC-9.4%) commences the commercial launch of its AcrySof IQ Vivity intraocular lens (IOL) in select European markets (additional countries will be added this year). The company says Vivity ...

Aging is a natural part of life, and as we grow older, our bodies go through various changes. Our hair turns gray, our joints ache a bit more and our energy levels fluctuate. But one aspect of aging ...

GENEVA--(BUSINESS WIRE)-- Regulatory News: Alcon (SIX/NYSE:ALC), the global leader in eye care announced AcrySof® IQ Vivity®, a first-of-its-kind intraocular lens (IOL) is now commercially available ...